Danish Pharmaceuticals & Biotech Leverage Leaders

ALK-Abelló

Market Cap: DKK 49.1b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

Bavarian Nordic

Market Cap: DKK 14.1b

Develops, manufactures, and supplies life-saving vaccines.

Zealand Pharma

Market Cap: DKK 18.1b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.